TotalSeq™-C0206 anti-human CD169 (Sialoadhesin, Siglec-1) Antibody, CD169, 7-239,BioLegend,346021

Additional reported applications (for the relevant formats) include: Western blotting and inhibition of erythrocyte-rosetting with cells expressing CD169.

Host

Mouse

Reactivity

Human

Application

PG -Quality tested

Platform ID

BAB696167732

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-C0206 anti-human CD169 (Sialoadhesin, Siglec-1) Antibody, CD169, 7-239
Cat. No.346021
HostMouse
RRIDAB_2810551 (BioLegend Cat. No. 346021)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationPG -Quality tested
ClonalityMonoclonal
Clone Number7-239
Concentration0.5 mg/ml
TargetCD169
ImmunogenHuman Rhinovirus (HRV14) infected, monocyte derived-DCs
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-C oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD169, also known as Siglec-1 and Sialoadhesin (Sn), is a 210 kD type I single membrane-spanning glycoprotein. It is the largest member of the Siglec family, consisting of 1709 amino acids and belonging to the immunoglobulin superfamily. CD169 is expressed by macrophages and dendritic cells. By its affinity to α2,3-linked sialic acid, it is involved in macrophage binding to different cell types such as granulocytes, monocytes, NK, B and T cells. Several CD169 counter receptors, such as CD227 on human breast cancer cells, CD43 on T cells and CD206 on macrophages, have been reported.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.